Solid forms of ttk inhibitor
AssigneeUniversity Health Network
InventorsSze-Wan Li, Heinz W. Pauls, Peter Brent Sampson
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel co-crystal of the compound of formula (I): (Formula (I)) wherein the co-former molecule is bisphosphate hemihydrate, to processes for the preparation of the co-crystal, to pharmaceutical compositions containing the co-crystal, to the use of such a co-crystal in the manufacture of a medicament for use in the treatment of cancer and to methods of treating such diseases in the human or animal body by administering a therapeutically effective amount of such a co-crystal.
Claims25
A co-crystal of compound (I) and a co-former molecule,
- or a solvate of the co-crystal, wherein the co-former molecule is phosphoric acid.
(canceled)
(canceled)
A hydrobromide salt of compound (I) represented by the following structure formula:
- or a solvate thereof, wherein the molar ratio between compound (I) and hydrobromic acid is 1:1.
(canceled)
23-25. (canceled)
27-29. (canceled)
Dependencies are inferred from the claim text.